CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,008 | -99.9% | 121,122 | -40.6% | 0.02% | -5.6% |
| Q2 2022 | $1,430,000 | +694.4% | 203,993 | +837.9% | 0.02% | +800.0% |
| Q1 2022 | $180,000 | -56.6% | 21,751 | -64.5% | 0.00% | -50.0% |
| Q4 2021 | $415,000 | +9.5% | 61,315 | -14.3% | 0.00% | -20.0% |
| Q3 2021 | $379,000 | +151.0% | 71,509 | +171.7% | 0.01% | +150.0% |
| Q2 2021 | $151,000 | +7.9% | 26,318 | -37.1% | 0.00% | +100.0% |
| Q4 2020 | $140,000 | +197.9% | 41,827 | +308.7% | 0.00% | 0.0% |
| Q2 2020 | $47,000 | – | 10,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |